Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase NA 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Endocrine 5NET 4Genitourinary 1

Conditions

Rectal Neoplasms 1Neuroendocrine Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Gastric Cancer After D2 Lymph Node Dissection 1Gallbladder Neoplasms 1Carcinoma, Hepatocellular 1Anastomotic Leak 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Somatostatin × Gastrointestinal × Clear all
NCT07605611 2026-05-26

SC-Stoma

Tongji Hospital

Phase NA Recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT05701241 2024-06-14

SAUNA

University Hospital, Antwerp

Phase 4 Recruiting
270 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT01053390 2013-12-20

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 3 Completed
216 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT01914692 2013-08-02

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

First Affiliated Hospital, Sun Yat-Sen University

Phase 4 Completed
2 enrolled
Gastrointestinal

Gastric Cancer After D2 Lymph Node Dissection

NCT00386984 2006-10-12

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

University Hospital Freiburg

Phase 3 Completed
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡